Mount Yale Investment Advisors LLC Purchases 170 Shares of Encompass Health Co. (NYSE:EHC)

Mount Yale Investment Advisors LLC boosted its position in Encompass Health Co. (NYSE:EHC) by 6.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,749 shares of the company’s stock after acquiring an additional 170 shares during the quarter. Mount Yale Investment Advisors LLC’s holdings in Encompass Health were worth $236,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Principal Securities Inc. acquired a new position in shares of Encompass Health during the 4th quarter worth $25,000. Parallel Advisors LLC lifted its holdings in shares of Encompass Health by 192.3% in the fourth quarter. Parallel Advisors LLC now owns 573 shares of the company’s stock worth $38,000 after acquiring an additional 377 shares during the last quarter. Oakworth Capital Inc. acquired a new stake in shares of Encompass Health in the 2nd quarter valued at approximately $40,000. Benjamin F. Edwards & Company Inc. grew its holdings in shares of Encompass Health by 58.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after purchasing an additional 198 shares during the last quarter. Finally, GAMMA Investing LLC increased its position in Encompass Health by 31.9% during the 1st quarter. GAMMA Investing LLC now owns 616 shares of the company’s stock worth $51,000 after purchasing an additional 149 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Encompass Health news, CFO Douglas E. Coltharp sold 12,260 shares of the firm’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $86.34, for a total value of $1,058,528.40. Following the completion of the sale, the chief financial officer now directly owns 136,227 shares in the company, valued at $11,761,839.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 2.10% of the stock is currently owned by company insiders.

Encompass Health Trading Up 2.6 %

EHC opened at $95.26 on Wednesday. The stock has a market cap of $9.59 billion, a PE ratio of 25.75, a price-to-earnings-growth ratio of 1.39 and a beta of 0.88. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.08. Encompass Health Co. has a twelve month low of $57.55 and a twelve month high of $95.96. The company has a fifty day moving average of $90.35 and a 200-day moving average of $85.62.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, August 5th. The company reported $1.11 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.10. Encompass Health had a return on equity of 17.83% and a net margin of 7.88%. The firm had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.30 billion. During the same period last year, the company posted $0.95 EPS. The business’s quarterly revenue was up 9.6% on a year-over-year basis. On average, sell-side analysts predict that Encompass Health Co. will post 4.18 EPS for the current year.

Encompass Health announced that its Board of Directors has approved a share repurchase plan on Wednesday, July 24th that permits the company to repurchase $500.00 million in shares. This repurchase authorization permits the company to repurchase up to 5.4% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st will be given a dividend of $0.17 per share. This is an increase from Encompass Health’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Tuesday, October 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.71%. Encompass Health’s dividend payout ratio (DPR) is 18.38%.

Analyst Upgrades and Downgrades

EHC has been the topic of a number of research reports. Stephens reaffirmed an “overweight” rating and set a $105.00 target price on shares of Encompass Health in a research note on Tuesday, August 6th. Leerink Partnrs upgraded Encompass Health to a “strong-buy” rating in a research report on Wednesday, July 10th. UBS Group boosted their price target on Encompass Health from $96.00 to $100.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Truist Financial raised their price objective on shares of Encompass Health from $100.00 to $104.00 and gave the company a “buy” rating in a report on Thursday, August 15th. Finally, Leerink Partners started coverage on shares of Encompass Health in a report on Wednesday, July 10th. They set an “outperform” rating and a $100.00 target price on the stock. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Buy” and an average target price of $100.38.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.